Journals / Perinatoloji Dergisi / 2019 / Cilt: 27 - Sayı: 3

Does serum homocysteine level have a role in the early pregnancy loss?

Erken gebelik kayıplarında serum homosistein düzeyinin rolü var mıdır?

Pages
189–193
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: High homocysteine levels detected during early weeks of gestation can be a warning about the miscarriage risk, and also may provide insight about the obstetric complications that may develop in the further weeks of gestation such as preeclampsia, ablatio placentae and intrauterine growth restriction.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To investigate the relationship between high maternal homocysteine levels and early pregnancy losses.
📊
Key Findings & Data:Methods: Seventy patients diagnosed with miscarriage (missed, incomplete and threatened) between 5 and 12 weeks of gestation and 54 pregnant women without any problem during their follow-up were compared in terms of homocysteine levels during pregnancy.
💡
Conclusion & Impact:Conclusion: High homocysteine levels detected during early weeks of gestation can be a warning about the miscarriage risk, and also may provide insight about the obstetric complications that may develop in the further weeks of gestation such as preeclampsia, ablatio placentae and intrauterine growth restriction.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To investigate the relationship between high maternal homocysteine levels and early pregnancy losses. Methods: Seventy patients diagnosed with miscarriage (missed, incomplete and threatened) between 5 and 12 weeks of gestation and 54 pregnant women without any problem during their follow-up were compared in terms of homocysteine levels during pregnancy. Results: The highest mean serum homocysteine level among the miscarriage groups was in the threatened miscarriage group (8.9±3.9 nmol/l), followed by 7.8±2.5 and 8.7±4.2 nmol/l in the missed and incomplete miscarriage groups, respectively. The mean serum homocysteine level in the control group was 4.8±0.9 nmol/l. The homocysteine levels of the control group were significantly lower than all three miscarriage groups (p 0.05). When compared to the control group, the most significant difference among the serum homocysteine levels was found in the missed miscarriage (p<0.01). Conclusion: High homocysteine levels detected during early weeks of gestation can be a warning about the miscarriage risk, and also may provide insight about the obstetric complications that may develop in the further weeks of gestation such as preeclampsia, ablatio placentae and intrauterine growth restriction.

Özet

Amaç: Yüksek maternal homosistein düzeyleri ile erken gebelik kay›plar› aras›ndaki iliflkiyi araflt›rmak. Yöntem: 5–12. gebelik haftalar› aras›nda abortus (misssed, inkomplet ve imminens) tan›s› alan 70 hasta, takiplerinde sorun olmayan 54 gebe ile gebe homosistein düzeyleri aç›s›ndan karfl›laflt›r›ld›. Bulgular: Abortus gruplar›nda en yüksek serum homosistein düzeyi ortalamas› abortus imminens grubunda tespit edildi (8.9±3.9 nmol/l), bu ortalama missed abortus ve inkomplet abortus gruplar› nda s›ras›yla 7.8±2.5 ve 8.7±4.2 nmol/l olarak bulundu. Kontrol grubunda serum homosistein düzeyi ortalamas› 4.8±0.9 nmol/l olarak saptand›. Kontrol grubunun homosistein düzeyleri her üç abortus grubundan anlaml› düzeyde düflüktü (p 0.05). Kontrol grubu ile karfl›laflt›r›ld›¤›nda serum homosistein düzeyleri aras›nda en anlaml› fark missed abortus grubunda saptand› (p<0.01). Sonuç: Erken gebelik haftalar›nda tespit edilen yüksek homosistein düzeyleri, abortus riski hakk›nda uyar›c› olabilece¤i gibi ilerleyen haftalarda geliflebilecek olan preeklampsi, plasenta dekolman› ve intrauterin geliflme gerili¤i gibi obstetrik komplikasyonlar hakk› nda da fikir verebilir.

🔖

Cite This Article

ŞANLIKAN, F., ÖZBAY, K., GOCMEN, A., ALTUNCU, F. T., AVCI, M. E. (2019). Does serum homocysteine level have a role in the early pregnancy loss?. Perinatoloji Dergisi, Cilt: 27 - Sayı: 3, 189–193. https://ajindex.com/articles/417598

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. ACOG Practice Bulletin No. 200 Summary: early pregnancy loss. Obstet Gynecol 2018;132:1311–3
  2. Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ 2019;364:l869
  3. Gindler J, Li Z, Berry RJ, Correa A, Sun X, Wong L, et al.; Jiaxing City Collaborative Project on Neural Tube Defect Prevention. Folic acid supplements during pregnancy and risk of miscarriage. Lancet 2001;358:796–800
  4. Hekmati Azar Mehrabani Z, Ghorbanihaghjo A, Sayyah Melli M, Hamzeh-Mivehroud M, Fathi Maroufi N, Bargahi N, et al. Effects of folic acid supplementation on serum homocysteine and lipoprotein (a) levels during pregnancy. Bioimpacts 2015; 5:177–82
  5. Sukumar N, Adaikalakoteswari A, Venkataraman H, Maheswaran H, Saravanan P. Vitamin B12 status in women of childbearing age in the UK and its relationship with national nutrient intake guidelines: results from two National Diet and Nutrition Surveys. BMJ Open 2016;6:e011247
  6. Barnabé A, Aléssio AC, Bittar LF, de Moraes Mazetto B, Bicudo AM, de Paula EV, et al. Folate, vitamin B12 and homocysteine status in the post-folic acid fortification era in different subgroups of the Brazilian population attended to at a public health care center. Nutr J 2015;14:19
  7. Ocal P, Ersoylu B, Cepni I, Guralp O, Atakul N, Irez T, et al. The association between homocysteine in the follicular fluid with embryo quality and pregnancy rate in assisted reproductive techniques. J Assist Reprod Genet 2012;29:299–304
  8. Sayyah-Melli M, Ghorbanihaghjo A, Alizadeh M, Kazemi- Shishvan M, Ghojazadeh M, Bidadi S. The effect of high dose folic acid throughout pregnancy on homocysteine (Hcy) concentration and pre-eclampsia: a randomized clinical trial. PLoS One 2016;11:e0154400
  9. Gaiday AN, Tussupkaliyev AB, Bermagambetova SK, Zhumagulova SS, Sarsembayeva LK, Dossimbetova MB, et al. Effect of homocysteine on pregnancy: a systematic review. Chem Biol Interact 2018;293:70–6
  10. Wouters MG, Boers GH, Blom HJ, Trijbels FJ, Thomas CM, Borm GF, et al. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993;60:820–5
  11. Zeng Y, Li M, Chen Y, Wang S. Homocysteine, endothelin-1 and nitric oxide in patients with hypertensive disorders complicating pregnancy. Int J Clin Exp Pathol 2015;8:15275–9
  12. Sun F, Qian W, Zhang C, Fan JX, Huang HF. Correlation of maternal serum homocysteine in the first tri